TRV GP VI, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001990716

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2025 · 4 positions · Total reported value $64.22M · Top-10 concentration 100.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 25.0% · 1 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2025 13F filing, TRV GP VI, LLC disclosed 4 equity positions with a combined reported value of $64.22M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were SEPN ($44.52M), RAPP ($11.02M), CRGX ($7.69M). By sector, the heaviest allocations are Health Care 88.0%, Other 12.0%. Versus the prior quarter, allocation shifted toward Health Care (+6.1pp) and away from Other (-6.1pp).

Versus the prior quarter, TRV GP VI, LLC opened 1 new positions, trimmed 0 and fully exited 0, a turnover rate of 25.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest TRV GP VI, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-30 Award Rapport Therapeutics, Inc. 1,190,476 $21.00 SEC filing
2026-10-30 Award Rapport Therapeutics, Inc. 238,095 $21.00 SEC filing
2026-08-12 Sell Septerna, Inc. 141 $51.08 SEC filing
2026-08-12 Sell Septerna, Inc. 147,059 $50.27 SEC filing
2026-05-26 Sell Rapport Therapeutics, Inc. 18,572 $40.05 SEC filing
2026-05-11 Sell Rapport Therapeutics, Inc. 133,618 $40.24 SEC filing
2026-05-08 Sell Rapport Therapeutics, Inc. 5,018 $40.31 SEC filing
2026-05-07 Sell Rapport Therapeutics, Inc. 271,495 $40.12 SEC filing

All insider transactions →

Fund Profile

TRV GP VI files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 4 positions worth $232.28M in total. HoldingsHub carries 7 quarters of its filings (Q4 2024–Q2 2026).

Portfolio Structure

  • 4 positions · $232.28M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: SEPN (SEPTERNA INC) at 60.7%
  • Average position size: $58.07M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 88.0%
Other 12.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 4.21M $44.52M 69.32%
69.32%
Hold
2 969.22K $11.02M 17.16%
Form 4 · 2 →
17.16%
Hold
3 1.87M $7.69M 11.98%
11.98%
Hold
4 194.17K $994.17K 1.55%
1.55%
Hold

FAQ

What did TRV GP VI, LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, TRV GP VI, LLC reported 4 equity positions worth $64.22M in aggregate; its largest disclosed positions were SEPN ($44.52M), RAPP ($11.02M), CRGX ($7.69M).

How large is TRV GP VI, LLC's portfolio?

TRV GP VI, LLC reported $64.22M of long equity holdings across 4 positions as of 2025-Q2. Top-10 holdings account for 100.0% of reported value.

What is TRV GP VI, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/trv-gp-vi/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →